<--- Back to Details
First PageDocument Content
Cytogenetics / Lymphocytic leukemia / Acute leukemia / Myeloid leukemia / Acute lymphoblastic leukemia / Chromosomal translocation / Fluorescence in situ hybridization / Philadelphia chromosome / Abl gene / Biology / Genetics / Oncology
Date: 2015-05-18 15:03:10
Cytogenetics
Lymphocytic leukemia
Acute leukemia
Myeloid leukemia
Acute lymphoblastic leukemia
Chromosomal translocation
Fluorescence in situ hybridization
Philadelphia chromosome
Abl gene
Biology
Genetics
Oncology

OncologyTestRequest Form_2_04.indd

Add to Reading List

Source URL: www.mayomedicallaboratories.com

Download Document from Source Website

File Size: 1,88 MB

Share Document on Facebook

Similar Documents

The Dual E-selectin/CXCR4 Antagonist GMI-1359 Exerts Anti-leukemia Efficacy Against FLT3-ITDmutated Acute Myeloid Leukemia in A Patient-derived Xenograft Murine Model Mouse-1 Mouse-2

DocID: 1uSbg - View Document

A Phase I/II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date Dan

DocID: 1uJQ2 - View Document

Vascular E-Selectin Mediates Chemo-Resistance in Acute Myeloid Leukemia Initiating Cells Via Canonical Receptors PSGL-1 (CD162) and Hcell (CD44) and AKT Signaling Ingrid G Winkler, PhD1*, Johanna M Erbani, PhD student2*,

DocID: 1u5Xi - View Document

Regulatory Perspective: Acute Leukemia Clinical Endpoints Nancy S. Scher, MD, FACP DODP, CDER, FDA 1

DocID: 1tdCV - View Document

· ACUTE LYMPHOBL ASTIC LEUKEMIA · Incorporating Antibodies into Treatment Strategies for Acute Lymphoblastic Leukemia Nicholas J. Short, MD, and Elias Jabbour, MD

DocID: 1shAS - View Document